출판 : MarketsandMarkets (마켓츠앤마켓츠) 출판년월 : 2022년09월
카나비스(Cannabis) 시장 : 제품 유형(꽃, 농축물, 식용, 외용약 및 팅크제), 화합물(THC 도미넌트, CBD 도미넌트, 균형 THC, CBD), 용도(의료, 레크리에이션), 지역별(북미, 남미, 유럽, RoW) – 2027년까지의 세계 예측
Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe and RoW) – Global Forecast to 2027
페이지수 | 290 |
도표수 | 304 |
구성 | 영문조사보고서 |
가격 |
The global cannabis market size is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value. The cannabis market is driven by the rise in the use of cannabis for recreational and medical use. Moreover, there has been an increased legalization of cannabis in the US in states like Virginia in 2021 and Rhode Island in 2022 and in other countries like in Malta in 2021, and Thailand in 2018.
세계 카나비스 시장 규모는 2022년 277억 달러에서 2027년까지 823억 달러에 이를 것으로 예상되며, 가치 기준으로 CAGR 24.3%를 기록할 것입니다. 카나비스 시장은 레크리에이션 및 의료용 카나비스 사용의 증가에 의해 주도됩니다. 또한 2021년 버지니아와 2022년 로드 아일랜드와 2021년 몰타, 2018년 태국과 미국같은 다른 국가에서 카나비스 합법화가 증가했습니다.
The cannabis industry is growing rapidly and witnessing a double-digit growth rate globally. There are several major companies operating in the cannabis segment that dominate their respective markets. Thus, companies are competing to gain a significant market share. The leading players in the cannabis market and medical industry are undertaking inorganic growth strategies, such as expansions & investments and acquisitions—to increase their profits and market shares. For instance, in May 2020, Aurora Cannabis Inc. completed the acquisition of Reliva LLC (US), a leader in the sales of hemp-derived CBD products in the US. The acquisition took place for USD 40 million of Aurora’s common shares. This acquisition would enable the company to strengthen its position in the market and increase profitability.
“By application, the recreational segment is projected to grow at the highest CAGR during the forecast period.”
Recreational cannabis demand is increasing continuously driven by Gen Z consumers. A small but encouraging portion of cannabis products are being sold to women due to a shift in public opinion, and this percentage is predicted to increase over time. Moreover, legalization has have led to a trend toward cannabis-related tourism, with locations producing novel holiday items to entice clients and increasing travel bookings to cannabis-legal destinations.
“By compound, the THC-dominant segment is estimated to account for the largest share.”
THC strain is used for both medical and recreational applications, which increases its demand among manufacturers as well as consumers. Growing Together Research Inc., an Indiana-based biotechnology business, has created a new technique for genetically regulating the expression of Delta-9-THC in cannabis, including the capacity to boost cannabinoid levels in marijuana varieties grown for recreational or medical purposes. Moreover, other forms of THC, such as delta-8-THC, are gaining popularity in addition to the conventional version.
“The Europe region is projected to grow at the highest CAGR during the forecast period”
The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions. As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region. Since the beginning of 2019, the European cannabis market has witnessed multiple mergers and acquisitions involving companies focused on medical cannabis. Like in the starting of 2021 medical cannabis firm GW Pharmaceutical was acquired by Jazz Pharmaceutical for USD 6.15 Billion.
Break-up of Primaries:
By Value Chain Side: Demand Side-59%, Supply Side-41%
By Designation: CXOs-31%, Managers – 24%, D-Level- 30%, and Executives- 45%
By Region: Europe – 25%, Asia Pacific – 15%, North America – 45%, RoW – 5%, South America-10%
Leading players profiled in this report:
• Canopy Growth Corporation (Canada)
• Aurora Cannabis Inc. (Canada)
• Medmen Enterprise Inc. (US)
• Tilray Inc. (US)
• Unrivaled Brand Inc. (US)
• VIVO Cannabis Inc. (Canada)
• The Cronos Group (Canada)
• Medical Marijuana Inc. (US)
• Stenocare (Denmark)
• Trulieve (US)
• Organigrams Holding Inc. (Canada)
• Cresco Labs (US)
• Maricann Group Inc. (Canada)
• Indiva (Canada)
• Hexo Corp. (Canada)
• Ecofibre Limited (Australia)
• Curaleaf Holdings Inc. (US)
• Harvest Health and Recreation (US)
• Green Thumb Industries (US)
• TerrAscend (Canada)
Research Coverage:
The report segments the cannabis market on the basis on product type, application, compound, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global cannabis, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
• To get a comprehensive overview of the cannabis market
• To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
• To gain insights about the major countries/regions in which the cannabis market is flourishing
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 36)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 MARKET SEGMENTATION
1.3.1 INCLUSIONS AND EXCLUSIONS
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2017–2021
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 41)
2.1 RESEARCH DATA
FIGURE 2 CANNABIS MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 CANNABIS MARKET SIZE ESTIMATION, BY TYPE (SUPPLY-SIDE)
FIGURE 5 CANNABIS MARKET SIZE ESTIMATION (DEMAND-SIDE)
2.2.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 6 CANNABIS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 7 CANNABIS MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION
2.4 ASSUMPTIONS
2.5 RESEARCH LIMITATIONS AND ASSOCIATED RISKS
3 EXECUTIVE SUMMARY (Page No. – 52)
TABLE 2 CANNABIS MARKET SHARE SNAPSHOT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 CANNABIS MARKET SIZE, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 10 CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 11 CANNABIS MARKET SIZE, BY COMPOUND, 2022 VS. 2027 (USD MILLION)
FIGURE 12 CANNABIS MARKET SHARE AND GROWTH RATE (VALUE), BY REGION, 2021
4 PREMIUM INSIGHTS (Page No. – 56)
4.1 ATTRACTIVE OPPORTUNITIES IN CANNABIS MARKET
FIGURE 13 GROWING MEDICINAL APPLICATIONS AND INCREASING LEGALIZATION OF CANNABIS CREATE OPPORTUNITIES IN MARKET
4.2 CANNABIS MARKET: MAJOR REGIONAL SUBMARKETS
FIGURE 14 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE GLOBALLY IN 2021
4.3 NORTH AMERICA: CANNABIS MARKET, BY COMPOUND AND COUNTRY
FIGURE 15 IN 2021, US ACCOUNTED FOR LARGEST SHARE IN NORTH AMERICA
4.4 CANNABIS MARKET, BY APPLICATION
FIGURE 16 RECREATIONAL SEGMENT TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD
4.5 CANNABIS MARKET, BY COMPOUND
FIGURE 17 TETRAHYDROCANNABINOL (THC)-DOMINANT COMPOUND TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD
4.6 CANNABIS MARKET, BY PRODUCT TYPE AND REGION
FIGURE 18 NORTH AMERICA TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. – 59)
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 INCREASE IN AGING POPULATION
FIGURE 19 INCREASING POPULATION OF INDIVIDUALS AGED 60 AND ABOVE (2021–2021)
5.2.2 ECONOMIC DOWNTURN
FIGURE 20 UNEMPLOYMENT AS A PERCENTAGE OF TOTAL LABOR FORCE (2010–2021)
5.3 MARKET DYNAMICS
FIGURE 21 CANNABIS MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Rising cannabis demand for medicinal applications
5.3.1.2 Legalization of cannabis and rise in social acceptance
FIGURE 22 GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 2020
5.3.1.3 Growth in R&D activities and technological advancements to be precursors for cannabis business
5.3.1.4 Rising global cannabis sales helping online retailers expand
5.3.2 RESTRAINTS
5.3.2.1 Complex regulatory structure for use of cannabis
5.3.2.2 Problems associated with high dose of cannabis consumption
5.3.2.3 Stigmatization of cannabis market
5.3.2.4 Profit margins of manufacturers shrinks as cannabis prices fall
FIGURE 23 AVERAGE SELLING PRICES OF CANNABIS, 2019–2022
5.3.3 OPPORTUNITIES
5.3.3.1 Emergence of cannabis legalization in Asia Pacific
5.3.3.2 Edibles, led by gummies and chocolates, to present additional growth opportunities for cannabis business
5.3.3.3 Inorganic growth strategies adopted by US cannabis companies
5.3.4 CHALLENGES
5.3.4.1 Intensive water consumption and inability to maintain consistency during cannabis cultivation
5.3.4.2 Cannabis-producing businesses face financing difficulties in US
5.3.4.3 Advertising and marketing restrictions in US
5.3.4.4 Supply chain challenges associated with cannabis in US
6 INDUSTRY TRENDS (Page No. – 73)
6.1 INTRODUCTION
6.2 VALUE CHAIN
6.2.1 RESEARCH AND PRODUCT DEVELOPMENT
6.2.2 RAW MATERIAL SOURCING
6.2.3 PRODUCTION
6.2.4 PACKAGING, STORAGE, AND DISTRIBUTION
6.2.5 RETAIL
FIGURE 24 CANNABIS MARKET: VALUE CHAIN
6.3 SUPPLY CHAIN ANALYSIS
FIGURE 25 CANNABIS MARKET: SUPPLY CHAIN
6.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
6.4.1 REVENUE SHIFT AND NEW REVENUE POCKETS IN CANNABIS MARKET
FIGURE 26 REVENUE SHIFT IMPACTING CANNABIS MARKET
6.5 MARKET MAPPING AND ECOSYSTEM OF CANNABIS MARKET
6.5.1 DEMAND-SIDE
6.5.2 SUPPLY-SIDE
FIGURE 27 CANNABIS MARKET ECOSYSTEM MAP
6.5.3 ECOSYSTEM MAP
TABLE 3 CANNABIS MARKET: ECOSYSTEM
6.6 TECHNOLOGY ANALYSIS
6.6.1 LED GLOW LIGHT
6.6.2 NANOENCAPSULATION
6.6.3 ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN
FIGURE 28 PROCESSES TRACKED BY USING SEED-TO-SALE TRACKER
6.6.4 CROP STEERING
6.6.5 VERTICAL FARMING
6.6.6 INNOVATIVE HARDWARE TECH DEVICES
6.6.7 IOT AUTOMATION
6.6.8 GENETIC ENGINEERING
6.7 PRICING ANALYSIS
6.7.1 SELLING PRICES CHARGED BY KEY PLAYERS IN TERMS OF PRODUCT TYPE
FIGURE 29 SELLING PRICES OF KEY PLAYERS FOR CANNABIS PRODUCT TYPE
TABLE 4 SELLING PRICE OF KEY PLAYERS FOR PRODUCT TYPE
FIGURE 30 AVERAGE SELLING PRICE IN KEY REGIONS, BY PRODUCT TYPE, 2018–2021 (USD/KG)
TABLE 5 FLOWER: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
TABLE 6 CONCENTRATES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
TABLE 7 EDIBLES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
TABLE 8 TOPICALS & TINCTURES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
TABLE 9 OTHER PRODUCT TYPES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG)
6.8 CANNABIS MARKET: PATENT ANALYSIS
FIGURE 31 NUMBER OF PATENTS GRANTED FOR CANNABIS MARKET, 2011–2021
FIGURE 32 TOP PATENT APPLICANTS FOR CANNABIS MARKET, 2019–2022
FIGURE 33 REGIONAL ANALYSIS OF PATENTS GRANTED FOR CANNABIS MARKET, 2019–2022
6.8.1 LIST OF MAJOR PATENTS
TABLE 10 LIST OF A FEW PATENTS IN CANNABIS MARKET, 2019–2022
6.9 TRADE ANALYSIS: CANNABIS MARKET
6.9.1 EXPORT SCENARIO OF HEMP
FIGURE 34 HEMP EXPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)
TABLE 11 EXPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)
6.9.2 IMPORT SCENARIO OF HEMP
FIGURE 35 HEMP IMPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND)
TABLE 12 IMPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME)
6.10 CASE STUDIES: CANNABIS MARKET
6.10.1 FILTER420: ATTEMPTS TO BUILD BRAND VALUE
6.10.2 ONYX AGRONOMICS: PRECISION CANNABIS FACILITY
6.11 KEY CONFERENCES AND EVENTS, 2022–2023
TABLE 13 KEY CONFERENCES AND EVENTS IN CANNABIS MARKET
6.12 TARIFF AND REGULATORY LANDSCAPE
6.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.12.2 REGULATORY FRAMEWORK
FIGURE 36 GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 2022
6.12.2.1 North America
FIGURE 37 US CANNABIS REGULATORY OVERVIEW, 2022
6.12.2.1.1 US
6.12.2.1.1.1 Alaska-legalization measure approved in November 2014
6.12.2.1.1.2 Arizona-legalization measure approved in November 2020
6.12.2.1.1.3 California-legalization measure approved in November 2016
6.12.2.1.1.4 Colorado-legalization measure approved in November 2012
6.12.2.1.1.5 Connecticut-legalization measure approved in June 2021
6.12.2.1.1.6 Guam-legalization measure approved in April 2019
6.12.2.1.1.7 Illinois-legalization measure approved in May 2019
6.12.2.1.1.8 Maine-legalization measure approved in November 2016
6.12.2.1.1.9 Massachusetts-legalization measure approved in November 2016
6.12.2.1.1.10 Michigan-legalization measure approved in November 2018
6.12.2.1.1.11 Montana-legalization measure approved in January 2021
6.12.2.1.1.12 New Jersey-legalization measure approved in November 2020
6.12.2.1.1.13 New Mexico- legalization measure approved in April 2021
6.12.2.1.1.14 New York-legalization measure approved in March 2021
6.12.2.1.1.15 Oregon-legalization measure approved in November 2014
6.12.2.1.1.16 Rhode Island-legalization measure approved in May 2022
6.12.2.1.1.17 Vermont-legalization measure approved in January 2018
6.12.2.1.1.18 Virginia-legalization measure approved in April 2021
6.12.2.1.1.19 Washington-legalization measure approved in November 2012
6.12.2.1.2 Canada
6.12.2.2 Europe
6.12.2.2.1 German-legalization measure approved in 2017
6.12.2.2.2 Italy-legalization measure approved in 2014
6.12.2.2.3 Denmark-legalization measure approved in January 2018
6.12.2.2.4 Malta-legalization measure approved in January 2018
6.12.2.2.5 Netherlands-legalization measure approved in January 2013
6.12.2.2.6 France-legalization measure approved in March 2022
6.12.2.2.7 Switzerland
6.12.2.2.8 UK
6.12.2.2.9 Belgium
6.12.2.2.10 Poland
6.12.2.2.11 Czech Republic
6.12.2.2.12 Spain
6.12.2.2.13 Austria
6.12.2.2.14 Norway
6.12.2.2.15 Finland
6.12.2.2.16 Croatia
6.12.2.3 South America
6.12.2.3.1 Chile-legalization measure approved in 2015
6.12.2.3.2 Colombia-legalization measure approved in 2015
6.12.2.3.3 Uruguay-legalization measure approved in December 2013
6.12.2.4 Rest of the world
6.12.2.4.1 Israel-legalization measure approved in December 2018
6.12.2.4.2 Australia-legalization measure approved in February 2016
6.12.2.4.3 Thailand
6.12.2.4.4 South Korea
6.12.2.4.5 Malaysia
6.12.2.4.6 South Africa
6.13 PORTER’S FIVE FORCES ANALYSIS
TABLE 18 CANNABIS MARKET: PORTER’S FIVE FORCES ANALYSIS
6.13.1 DEGREE OF COMPETITION
6.13.2 BARGAINING POWER OF SUPPLIERS
6.13.3 BARGAINING POWER OF BUYERS
6.13.4 THREAT OF SUBSTITUTES
6.13.5 THREAT OF NEW ENTRANTS
6.14 KEY STAKEHOLDERS AND BUYING CRITERIA
6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 38 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS
TABLE 19 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS (%)
6.14.2 BUYING CRITERIA
FIGURE 39 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR
TABLE 20 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR
7 CANNABIS MARKET, BY PRODUCT TYPE (Page No. – 110)
7.1 INTRODUCTION
FIGURE 40 CANNABIS MARKET SHARE (VALUE), BY PRODUCT TYPE, 2022 VS 2027
TABLE 21 CANNABIS MARKET, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 22 CANNABIS MARKET, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 23 CANNABIS MARKET, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 24 CANNABIS MARKET, BY PRODUCT TYPE, 2022–2027 (TONS)
7.2 FLOWERS
7.2.1 AUTOMATION AND SUSTAINABLE PACKAGING TO BE KEY TRENDS IN PRE-ROLL DOMAIN
TABLE 25 FLOWERS: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 26 FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 27 FLOWERS: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)
TABLE 28 FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)
7.3 CONCENTRATES
7.3.1 VARIOUS DELIVERY METHODS RESULTED IN CONSUMER-FRIENDLY CANNABIS CONCENTRATES MARKET
TABLE 29 CONCENTRATES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 30 CONCENTRATES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 31 CONCENTRATES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)
TABLE 32 CONCENTRATES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)
7.4 EDIBLES
7.4.1 FOOD AND BEVERAGE MANUFACTURING COMPANIES VENTURE INTO CANNABIS-INFUSED EDIBLES
TABLE 33 EDIBLES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 34 EDIBLES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 35 EDIBLES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)
TABLE 36 EDIBLES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)
7.5 TOPICALS & TINCTURES
7.5.1 TOPICALS WITNESS INCREASED DEMAND IN SKINCARE INDUSTRY
TABLE 37 TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 38 TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 39 TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)
TABLE 40 TOPICALS & TINCTURES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)
7.6 OTHER PRODUCT TYPES
TABLE 41 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 42 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 43 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS)
TABLE 44 OTHER PRODUCT TYPES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)
8 CANNABIS MARKET, BY COMPOUND (Page No. – 125)
8.1 INTRODUCTION
FIGURE 41 CANNABIS MARKET SHARE (VALUE), BY COMPOUND, 2022 VS 2027
TABLE 45 CANNABIS MARKET, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 46 CANNABIS MARKET, BY COMPOUND, 2022–2027 (USD MILLION)
8.2 TETRAHYDROCANNABINOL (THC)-DOMINANT
8.2.1 INCREASING LEGALIZATION OF RECREATIONAL CANNABIS PROPELS THC-DOMINANT CANNABIS MARKET
TABLE 47 THC-DOMINANT: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 48 THC-DOMINANT: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)
8.3 CANNABIDIOL (CBD)-DOMINANT
8.3.1 INCREASED POPULARITY OF CBD EDIBLES TO DRIVE CBD-DOMINANT CANNABIS PRODUCTS MARKET
TABLE 49 CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 50 CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)
8.4 BALANCED THC & CBD
8.4.1 BALANCED THC & CBD STRAINS WITNESS GROWTH AS CBD DIMINISHES PSYCHOACTIVE PROPERTIES OF THC
TABLE 51 BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 52 BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)
9 CANNABIS MARKET, BY APPLICATION (Page No. – 131)
9.1 INTRODUCTION
FIGURE 42 CANNABIS MARKET SHARE (VALUE), BY APPLICATION, 2022 VS 2027
TABLE 53 CANNABIS MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 54 CANNABIS MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
9.2 MEDICAL
9.2.1 INCREASE IN CANNABIS USE FOR TREATMENT OF VARIOUS AILMENTS DRIVES DEMAND FOR MEDICAL CANNABIS
9.2.1.1 Pain management
9.2.1.2 Neurological health management
9.2.1.3 Mental health management
9.2.1.4 Other medical applications
TABLE 55 MEDICAL: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 56 MEDICAL: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)
9.3 RECREATIONAL
9.3.1 WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS TO BOOST MARKET GROWTH
TABLE 57 RECREATIONAL: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION)
TABLE 58 RECREATIONAL: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION)
10 CANNABIS MARKET, BY REGION (Page No. – 140)
10.1 INTRODUCTION
FIGURE 43 REGIONAL SNAPSHOT: NEW HOTSPOTS TO EMERGE IN EUROPE, 2022–2027
TABLE 59 CANNABIS MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
TABLE 60 CANNABIS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 61 CANNABIS MARKET SIZE, BY REGION, 2018–2021 (TONS)
TABLE 62 CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS)
10.2 NORTH AMERICA
FIGURE 44 NORTH AMERICA: CANNABIS MARKET SNAPSHOT
TABLE 63 NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 64 NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 65 NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 66 NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 68 NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 70 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 71 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 72 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)
10.2.1 US
10.2.1.1 Increase in mergers, investments, and sales drive cannabis market in US
TABLE 73 US: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 74 US: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Presence of major players in Canada boosts growth during forecast period
TABLE 75 CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 76 CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.2.3 MEXICO
10.2.3.1 Medical cannabis used for epilepsy treatment boosts Mexican cannabis market growth
TABLE 77 MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 78 MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3 EUROPE
FIGURE 45 EUROPE: CANNABIS MARKET SNAPSHOT
TABLE 79 EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 80 EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 81 EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 82 EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)
TABLE 83 EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 84 EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
TABLE 85 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 86 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 87 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 88 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)
10.3.1 GERMANY
10.3.1.1 Health insurance coverage for cannabis use in medical treatments driving market
TABLE 89 GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 90 GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.2 ITALY
10.3.2.1 Increase in demand for cannabis and issuance of import licenses to drive market
TABLE 91 ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 92 ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.3 DENMARK
10.3.3.1 Huge demand for medical cannabis to drive Danish medical cannabis market
TABLE 93 DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 94 DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.4 NETHERLANDS
10.3.4.1 Strong infrastructure and rise in export of medical cannabis to other countries drive market
TABLE 95 NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 96 NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.5 FRANCE
10.3.5.1 Government providing finance to healthcare systems and refunds provided to patients
TABLE 97 FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 98 FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 99 REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 100 REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.4 SOUTH AMERICA
TABLE 101 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 102 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 103 SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 104 SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)
TABLE 105 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 106 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
TABLE 107 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 108 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 109 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 110 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)
10.4.1 CHILE
10.4.1.1 Rise in consumption of cannabis for medical usage driving market
TABLE 111 CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 112 CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.4.2 COLOMBIA
10.4.2.1 Increased cannabis license distribution to companies drives market
TABLE 113 COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 114 COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.4.3 URUGUAY
10.4.3.1 Fully legalized cannabis industry with eased regulations drives market
TABLE 115 URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 116 URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.4.4 REST OF SOUTH AMERICA
TABLE 117 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
FALSE
10.5 ROW
TABLE 119 ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
TABLE 120 ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 121 ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION)
TABLE 122 ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION)
TABLE 123 ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 124 ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
TABLE 125 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION)
TABLE 126 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION)
TABLE 127 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS)
TABLE 128 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS)
10.5.1 ISRAEL
10.5.1.1 Technical innovations and increased exports to drive market
TABLE 129 ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 130 ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.5.2 AUSTRALIA
10.5.2.1 Surge in epilepsy, chronic pain, and cancer patients resulted in market growth
TABLE 131 AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 132 AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
10.5.3 OTHERS IN ROW
TABLE 133 OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION)
TABLE 134 OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. – 176)
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, 2021
TABLE 135 CANNABIS MARKET: DEGREE OF COMPETITION (FRAGMENTED)
11.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS
FIGURE 46 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN MARKET, 2017–2021 (USD MILLION)
11.4 KEY PLAYER STRATEGIES
TABLE 136 STRATEGIES ADOPTED BY KEY CANNABIS MANUFACTURERS
11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 47 CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)
11.5.5 PRODUCT FOOTPRINT
TABLE 137 COMPANY FOOTPRINT, BY APPLICATION
TABLE 138 COMPANY FOOTPRINT, BY TYPE
TABLE 139 COMPANY FOOTPRINT, BY REGION
TABLE 140 OVERALL COMPANY FOOTPRINT
11.6 CANNABIS MARKET: EVALUATION QUADRANT FOR STARTUPS/SMES, 2021
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 48 CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (STARTUPS/SMES)
11.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 141 CANNABIS MARKET: DETAILED LIST OF KEY STARTUP/SMES
TABLE 142 CANNABIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
11.7.1 PRODUCT LAUNCHES
TABLE 143 CANNABIS: PRODUCT LAUNCHES, 2019–2022
11.7.2 DEALS
TABLE 144 CANNABIS: DEALS, 2019–2022
11.7.3 OTHERS
TABLE 145 CANNABIS: OTHERS, 2019–2022
12 COMPANY PROFILES (Page No. – 193)
12.1 INTRODUCTION
12.2 KEY PLAYER
(Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)*
12.2.1 CANOPY GROWTH CORPORATION
TABLE 146 CANOPY GROWTH CORPORATION: BUSINESS OVERVIEW
FIGURE 49 CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT
TABLE 147 CANOPY GROWTH CORPORATION: PRODUCTS OFFERED
TABLE 148 CANOPY GROWTH CORPORATION: NEW PRODUCT LAUNCHES
TABLE 149 CANOPY GROWTH CORPORATION: DEALS
TABLE 150 CANOPY GROWTH CORPORATION: OTHERS
12.2.2 CURALEAF
TABLE 151 CURALEAF: BUSINESS OVERVIEW
FIGURE 50 CURALEAF: COMPANY SNAPSHOT
TABLE 152 CURALEAF: PRODUCTS OFFERED
TABLE 153 CURALEAF: NEW PRODUCT LAUNCHES
TABLE 154 CURALEAF: DEALS
TABLE 155 CURALEAF: OTHERS
12.2.3 CRESCO LABS
TABLE 156 CRESCO LABS: BUSINESS OVERVIEW
FIGURE 51 CRESCO LABS: COMPANY SNAPSHOT
TABLE 157 CRESCO LABS: PRODUCTS OFFERED
TABLE 158 CRESCO LABS: NEW PRODUCT LAUNCHES
TABLE 159 CRESCO LABS: DEALS
TABLE 160 CRESCO LABS: OTHERS
12.2.4 GREEN THUMB INDUSTRIES
TABLE 161 GREEN THUMB INDUSTRIES: BUSINESS OVERVIEW
FIGURE 52 GREEN THUMB INDUSTRIES: COMPANY SNAPSHOT
TABLE 162 GREEN THUMB INDUSTRIES: PRODUCTS OFFERED
TABLE 163 GREEN THUMB INDUSTRIES: DEALS
TABLE 164 GREEN THUMB INDUSTRIES: OTHERS
12.2.5 TILRAY
TABLE 165 TILRAY: BUSINESS OVERVIEW
FIGURE 53 TILRAY: COMPANY SNAPSHOT
TABLE 166 TILRAY INC: PRODUCTS OFFERED
TABLE 167 TILRAY: NEW PRODUCT LAUNCHES
TABLE 168 TILRAY: DEALS
TABLE 169 TILRAY: OTHERS
12.2.6 TRULIEVE
TABLE 170 TRULIEVE: BUSINESS OVERVIEW
FIGURE 54 TRULIEVE: COMPANY SNAPSHOT
TABLE 171 TRULIEVE: PRODUCTS OFFERED
TABLE 172 TRULIEVE: DEALS
TABLE 173 TRULIEVE: OTHERS
12.2.7 AURORA CANNABIS INC.
TABLE 174 AURORA CANNABIS INC.: BUSINESS OVERVIEW
FIGURE 55 AURORA CANNABIS INC.: COMPANY SNAPSHOT
TABLE 175 AURORA CANNABIS INC.: PRODUCTS OFFERED
TABLE 176 AURORA CANNABIS INC.: NEW PRODUCT LAUNCHES
TABLE 177 AURORA CANNABIS INC.: DEALS
TABLE 178 AURORA CANNABIS INC.: OTHERS
12.2.8 MEDMEN
TABLE 179 MEDMEN: BUSINESS OVERVIEW
FIGURE 56 MEDMEN: COMPANY SNAPSHOT
TABLE 180 MEDMEN: PRODUCTS OFFERED
TABLE 181 MEDMEN: OTHERS
12.2.9 UNRIVALED BRAND INC.
TABLE 182 UNRIVALED BRAND INC.: BUSINESS OVERVIEW
FIGURE 57 UNRIVALED BRAND INC.: COMPANY SNAPSHOT
TABLE 183 UNRIVALED BRAND INC.: PRODUCTS OFFERED
TABLE 184 UNRIVALED BRAND INC.: DEALS
TABLE 185 UNRIVALED BRAND INC.: OTHERS
12.2.10 ORGANIGRAM HOLDINGS INC.
TABLE 186 ORGANIGRAM HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 58 ORGANIGRAM HOLDINGS INC.: COMPANY SNAPSHOT
TABLE 187 ORGANIGRAM HOLDINGS INC.: PRODUCTS OFFERED
TABLE 188 ORGANIGRAM HOLDINGS INC.: PRODUCT LAUNCH
TABLE 189 ORGANIGRAM HOLDINGS INC.: DEALS
TABLE 190 ORGANIGRAM HOLDINGS INC.: OTHERS
12.2.11 STENOCARE
TABLE 191 STENOCARE: BUSINESS OVERVIEW
FIGURE 59 STENOCARE: COMPANY SNAPSHOT
TABLE 192 STENOCARE: PRODUCTS OFFERED
TABLE 193 STENOCARE: DEALS
TABLE 194 STENOCARE: OTHERS
12.2.12 VIVO CANNABIS INC.
TABLE 195 VIVO CANNABIS INC.: BUSINESS OVERVIEW
FIGURE 60 VIVO CANNABIS INC.: COMPANY SNAPSHOT
TABLE 196 VIVO CANNABIS INC.: PRODUCTS OFFERED
TABLE 197 VIVO CANNABIS INC.: NEW PRODUCT LAUNCHES
TABLE 198 VIVO CANNABIS INC.: DEALS
TABLE 199 VIVO CANNABIS INC.: OTHERS
12.2.13 TERRASCEND
TABLE 200 TERRASCEND: BUSINESS OVERVIEW
FIGURE 61 TERRASCEND: COMPANY SNAPSHOT
TABLE 201 TERRASCEND: PRODUCTS OFFERED
TABLE 202 TERRASCEND: DEALS
TABLE 203 TERRASCEND: OTHERS
12.2.14 HEXO CORP
TABLE 204 HEXO CORP: BUSINESS OVERVIEW
FIGURE 62 HEXO CORP: COMPANY SNAPSHOT
TABLE 205 HEXO CORP: PRODUCTS OFFERED
TABLE 206 HEXO CORP: NEW PRODUCT LAUNCHES
TABLE 207 HEXO CORP: DEALS
TABLE 208 HEXO CORP: OTHERS
12.2.15 VILLAGE FARMS INTERNATIONAL INC.
TABLE 209 VILLAGE FARMS INTERNATIONAL INC.: BUSINESS OVERVIEW
FIGURE 63 VILLAGE FARMS INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 210 VILLAGE FARMS INTERNATIONAL INC.: PRODUCTS OFFERED
TABLE 211 VILLAGE FARMS INTERNATIONAL INC.: OTHERS
12.2.16 VERANO
TABLE 212 VERANO: BUSINESS OVERVIEW
FIGURE 64 VERANO: COMPANY SNAPSHOT
TABLE 213 VERANO: PRODUCTS OFFERED
TABLE 214 VERANO: DEALS
TABLE 215 VERANO: OTHERS
12.3 OTHER PLAYERS (SMES/STARTUPS)
12.3.1 THE CRONOS GROUP
TABLE 216 THE CRONOS GROUP: BUSINESS OVERVIEW
FIGURE 65 THE CRONOS GROUP: COMPANY SNAPSHOT
TABLE 217 THE CRONOS GROUP: PRODUCTS OFFERED
TABLE 218 THE CRONOS GROUP: DEALS
TABLE 219 THE CRONOS GROUP: OTHERS
12.3.2 MEDICAL MARIJUANA, INC.
TABLE 220 MEDICAL MARIJUANA, INC.: BUSINESS OVERVIEW
FIGURE 66 MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT
TABLE 221 MEDICAL MARIJUANA, INC.: PRODUCTS OFFERED
TABLE 222 MEDICAL MARIJUANA, INC.: NEW PRODUCT LAUNCHES
TABLE 223 MEDICAL MARIJUANA, INC.: DEALS
TABLE 224 MEDICAL MARIJUANA, INC.: OTHERS
12.3.3 ECOFIBRE LIMITED
TABLE 225 ECOFIBRE LIMITED: BUSINESS OVERVIEW
FIGURE 67 ECOFIBRE LIMITED: COMPANY SNAPSHOT
TABLE 226 ECOFIBRE LIMITED: PRODUCTS OFFERED
TABLE 227 ECOFIBRE LIMITED: OTHERS
12.3.4 INDIVA
TABLE 228 INDIVA: BUSINESS OVERVIEW
FIGURE 68 INDIVA: COMPANY SNAPSHOT
TABLE 229 INDIVA: PRODUCTS OFFERED
TABLE 230 INDIVA: NEW PRODUCT LAUNCHES
TABLE 231 INDIVA: DEALS
TABLE 232 INDIVA: OTHERS
12.3.5 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.
TABLE 233 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: BUSINESS OVERVIEW
TABLE 234 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: PRODUCTS OFFERED
12.3.6 MARICANN GROUP INC
TABLE 235 MARICANN GROUP INC: BUSINESS OVERVIEW
TABLE 236 MARICANN GROUP INC: PRODUCTS OFFERED
12.3.7 SATIPHARM
12.3.8 CANNABLISS ORGANIC LLC
12.3.9 CONNECTED CANNABIS CO.
12.3.10 JUSTICE CANNABIS CO.
12.3.11 HENRY’S ORIGINAL
*Details on Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX (Page No. – 290)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATIONS OFFERED
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS